Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
Abstract Hereditary cancer syndromes constitute approximately 10% of all cancers. Cascade testing involves testing of at-risk relatives to determine if they carry the familial pathogenic variant. Despite growing efforts targeted at improving cascade testing uptake, current literature continues to re...
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Nature Portfolio
2024-04-01
|
| 叢編: | npj Genomic Medicine |
| 在線閱讀: | https://doi.org/10.1038/s41525-024-00412-0 |